Scandinavian ChemoTech AB (publ) is a corporate office located in Lund that specializes in the development of innovative treatment technologies for cancer care. The company has developed a patented treatment technology platform that focuses on improving the efficacy and safety of cancer treatments for both humans and animals. Their approach includes the utilization of IQwave™ technology, which is designed to enhance the treatment process, as well as TSE technology, which further supports their treatment methodologies.
The organization offers two commercial product lines that leverage its advanced technologies, aiming to provide effective solutions for tumor treatment. Scandinavian ChemoTech is committed to advancing life sciences and regularly shares updates through news and press releases, reflecting its ongoing efforts to contribute to a paradigm shift in cancer treatment approaches. The company's innovative mechanisms of action are central to its mission of improving outcomes in cancer care.